FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

33682211000001106: Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Jan 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
102534901000001114 Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
102535001000001114 Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet Has specific active ingredient Dapagliflozin propanediol monohydrate true Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet Has VMP Saxagliptin 5mg / Dapagliflozin 10mg tablets true Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet Has specific active ingredient Dapagliflozin propanediol monohydrate false Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet Has specific active ingredient Saxagliptin hydrochloride false Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Saxagliptin true Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dapagliflozin false Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet Has basis of strength substance Saxagliptin true Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet Has basis of strength substance Dapagliflozin true Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet Has specific active ingredient Saxagliptin hydrochloride true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets Is a True Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start